Hollencrest Capital Management Cuts Stock Position in Axon Enterprise, Inc $AXON

Hollencrest Capital Management decreased its position in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 94.0% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 150 shares of the biotechnology company’s stock after selling 2,330 shares during the period. Hollencrest Capital Management’s holdings in Axon Enterprise were worth $108,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the company. Brighton Jones LLC purchased a new position in shares of Axon Enterprise in the fourth quarter valued at approximately $480,000. NewEdge Advisors LLC lifted its holdings in Axon Enterprise by 41.1% during the 1st quarter. NewEdge Advisors LLC now owns 2,294 shares of the biotechnology company’s stock worth $1,207,000 after buying an additional 668 shares in the last quarter. Empowered Funds LLC boosted its position in Axon Enterprise by 8.4% in the 1st quarter. Empowered Funds LLC now owns 2,028 shares of the biotechnology company’s stock valued at $1,067,000 after buying an additional 157 shares during the period. Woodline Partners LP boosted its position in Axon Enterprise by 40.6% in the 1st quarter. Woodline Partners LP now owns 6,932 shares of the biotechnology company’s stock valued at $3,646,000 after buying an additional 2,003 shares during the period. Finally, Sivia Capital Partners LLC acquired a new position in shares of Axon Enterprise in the second quarter worth $284,000. 79.08% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on AXON shares. UBS Group reduced their price objective on Axon Enterprise from $840.00 to $610.00 and set a “neutral” rating on the stock in a research note on Wednesday, November 5th. Morgan Stanley reduced their price target on Axon Enterprise from $760.00 to $713.00 and set an “overweight” rating on the stock in a research report on Wednesday, December 17th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Axon Enterprise in a research note on Monday, December 29th. Royal Bank Of Canada began coverage on shares of Axon Enterprise in a research note on Monday, November 17th. They set an “outperform” rating and a $860.00 target price on the stock. Finally, Barclays decreased their price target on shares of Axon Enterprise from $861.00 to $702.00 and set an “overweight” rating for the company in a research note on Thursday, November 6th. Fourteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $805.71.

Axon Enterprise Trading Down 7.3%

AXON opened at $509.58 on Friday. The company has a debt-to-equity ratio of 0.57, a quick ratio of 2.89 and a current ratio of 3.12. Axon Enterprise, Inc has a one year low of $469.24 and a one year high of $885.91. The company has a market cap of $40.21 billion, a P/E ratio of 161.26, a PEG ratio of 17.31 and a beta of 1.41. The business’s 50-day simple moving average is $579.11 and its 200-day simple moving average is $671.49.

Axon Enterprise (NASDAQ:AXON) last posted its earnings results on Wednesday, November 5th. The biotechnology company reported $1.17 earnings per share for the quarter, missing the consensus estimate of $1.63 by ($0.46). The business had revenue of $710.64 million for the quarter, compared to analysts’ expectations of $704.83 million. Axon Enterprise had a return on equity of 4.29% and a net margin of 10.05%.Axon Enterprise’s revenue for the quarter was up 30.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.45 EPS. As a group, equities research analysts expect that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Insider Buying and Selling at Axon Enterprise

In other news, President Joshua Isner sold 20,000 shares of the company’s stock in a transaction on Monday, December 8th. The shares were sold at an average price of $552.60, for a total value of $11,052,000.00. Following the completion of the transaction, the president owned 249,502 shares in the company, valued at approximately $137,874,805.20. This represents a 7.42% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Jeri Williams sold 100 shares of Axon Enterprise stock in a transaction on Thursday, December 4th. The stock was sold at an average price of $550.63, for a total transaction of $55,063.00. Following the sale, the director owned 1,316 shares in the company, valued at $724,629.08. This represents a 7.06% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 60,540 shares of company stock worth $34,684,738. 4.40% of the stock is owned by insiders.

Key Axon Enterprise News

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Robert W. Baird reiterated a Buy rating on AXON, highlighting continued confidence from at least one major sell‑side firm which can provide support if management meets growth targets. Robert W. Baird Remains a Buy on Axon Enterprise (AXON)
• Positive Sentiment: Analysts and contributors (e.g., Seeking Alpha / AppLovin coverage) argue Axon’s AI and software strategy could ignite a new growth flywheel, supporting longer‑term revenue expansion and higher SaaS margins if execution continues. AppLovin: Axon Ignites A New Growth Flywheel
• Neutral Sentiment: Coverage is mixed: a Globe and Mail piece notes analysts are conflicted on AXON, reflecting divergence in views on growth vs. valuation that can increase volatility. Analysts Conflicted on These Industrial Goods Names: RTX (RTX) and Axon Enterprise (AXON)
• Neutral Sentiment: Valuation checkers are mixed: one note argues intrinsic value may sit notably below the current share price — a cautionary datapoint for value‑oriented investors but not a near‑term catalyst on its own. Axon Enterprise, Inc.’s (NASDAQ:AXON) Intrinsic Value Is Potentially 17% Below Its Share Price
• Negative Sentiment: A Yahoo piece highlights potential near‑term EPS pressure as Axon invests to build out AI‑driven software advantages — investors may be penalizing margin and EPS risk in the short run. Is Axon (AXON) Trading Near-Term EPS Pressure for a Deeper AI Software Advantage?
• Negative Sentiment: Market commentary and screening writeups flag that AXON has underperformed peers and recently experienced a sharper intraday dip than the broader market, which can trigger momentum selling. Axon Enterprise Inc. stock underperforms Thursday when compared to competitors
• Negative Sentiment: Zacks and other outlets called out a notable share decline versus the market in recent sessions, reinforcing bearish sentiment and pressuring short‑term technical levels. Axon Enterprise (AXON) Sees a More Significant Dip Than Broader Market
• Negative Sentiment: Short interest rose in January (to ~3.6% of float; ~3.9 days to cover as of mid‑January), a technical headwind that can amplify downside on negative news. (Market data summarized internally.)

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.